Corporate Policy
Corporate philosophy
“Shed new light on medical practice worldwide to save every irreplaceable life”
“For your precious life” is the basis of our action guidelines to carry out each mission, and “illuminating the world’s medical care with a new light” is the formulation policy of our management goal.
Acting with this corporate philosophy, we have been working on the practical application of BNCT since the establishment of the company, and our basic management policy is to provide new medical options to cancer patients.
Vision
Stella Pharma always seeks for innovation to become a company necessary to global medical sites through supply of one and only drug.
Stella Pharma becomes a reliable company through activities based on compliance-first.
Stella Pharma becomes a company who gives satisfaction and pride to every stakeholder through contribution to medical practice.
What does the logo convey?
The two circles represent the process of creating a prosperous future through unlimited consistency between the development of science and technology and the comfortable lives. It also symbolizes the unity of wisdom and courage of the people who support these efforts.
The corporate colors represent the irreplaceable earth and ocean, and our great mission to contribute to creating a prosperous society.
Quality policy
To realize our corporate philosophy, we endeavor to provide better pharmaceutical products to the medical sites. To achieve this, we must ensure that all activities related to our pharmaceuticals need to output with high quality. We have established the following quality policy and will implement it to provide better pharmaceutical products.
Pursuit of quality
We will continuously pursue high quality based on scientific facts at all stages such as research and development, manufacturing and sales to provide better possible pharmaceutical products.
Stable supply
We will stably provide trusted pharmaceuticals that needed in the medical sites.
Proper use
We will promote the proper use of our drugs by providing accurate information.
Assurance of reliability
We always attach great importance to compliance and comply with regulations and standards to become a pharmaceutical company trusted by society to provide better possible pharmaceutical products. We emphasize EHS and promote environmentally friendly activities. We confirm that all activities related to pharmaceutical products carried out adequately and guarantee reliability.
Management commitment
We will continue to carry out activities with faith to fulfill our social responsibility as a pharmaceutical company. To this end, we will allocate management resources appropriately and establish and maintain the necessary systems.
(Enacted on April 1, 2020)
Stella Pharma Corporation code of practice
As a company related to healthcare, we strive to build and maintain sound relationships with stakeholders in each country and region through fair and ethical promotion, based on the following policies and on the premise that transactions are conducted in compliance with laws and regulations and with due regard for social norms.
Compliance with regulations
We follow the laws, regulations, and guidelines regarding promotion in the countries and regions in which we operate, and conduct our activities under industry rules.
Appropriate promotional information
We will provide promotional information that maintains consistency, accuracy, and substantiation of product information that does not contradict the content of pharmaceutical approvals and encourage the proper use of our products.
Basic policy of interactions
Interactions will be based on integrity and transparency and will focus on providing medical professionals with pharmaceutical information, scientific and educational information, and support for medical research and education.
Interactions with healthcare professionals and others
We will not directly or indirectly provide or offer financial or in-kind benefits to healthcare professionals in return for prescribing, recommending, purchasing, supplying, administering, or promoting the use of medicines, so as not to influence their independent decision-making.
Interactions with patient groups
We will conduct all Interactions with patient groups in an ethical manner and will respect their independence.
Relationships with wholesalers
We will establish fair business relationships with wholesalers that ensure high ethical standards and transparency.
(Enacted on May 1, 2020)
